VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARCT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARCTArcturus Therapeutics Holdings Inc.
$10.35$294M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksARCTQuarterly Financials

Arcturus Therapeutics Holdings Inc. (ARCT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Arcturus Therapeutics Holdings Inc. (ARCT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ARCT Income Statement

Quarterly statement

ARCT Income Statement

Arcturus Therapeutics Holdings Inc. (ARCT) annual income statement — 15-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue18.3M2.96M610K3.08M17.15M24.51M29.38M21M38.81M45.98M32.6M25.08M43.38M10.52M80.28M160.29M13.37M27.09M5.24M5.79M
Revenue Growth %6.68%-87.93%-97.92%-85.33%-55.81%-46.69%-9.87%-16.26%-10.51%337.08%-59.4%-84.35%224.45%-61.17%1430.99%2666.53%448.58%1253.97%146.54%158.89%
Cost of Goods Sold00658K03.34M000000003.74M51.77M26.98M37.69M38.19M44.89M30.73M
COGS % of Revenue--107.87%-19.49%--------35.56%64.48%16.83%281.91%140.96%856.08%530.43%
Gross Profit02.96M-48K3.08M13.81M24.51M29.38M21M38.81M45.98M32.6M25.08M43.38M6.78M28.52M133.31M-24.32M-11.1M-39.65M-24.94M
Gross Margin %-100%-7.87%100%80.51%100%100%100%100%100%100%100%100%64.44%35.52%83.17%-181.91%-40.96%-756.08%-430.43%
Gross Profit Growth %-100%-87.93%-100.16%-85.33%-64.42%-46.69%-9.87%-16.26%-10.51%578.31%14.31%-81.19%278.36%161.09%171.92%634.55%43.39%74.6%17.27%-23.78%
Operating Expenses27.48M28.5M29.73M34.39M30.32M36.13M46.21M54.39M49.55M67.1M63.01M43.35M62.69M62.15M13.76M11.86M12.49M10.99M10.73M12.71M
OpEx % of Revenue150.2%963.3%4874.1%1116.13%176.79%147.39%157.27%259.02%127.66%145.95%193.29%172.86%144.53%590.85%17.14%7.4%93.41%40.58%204.61%219.3%
Selling, General & Admin10.48M10.99M8.81M14.03M10.4M10.34M11.31M12.38M13.28M12.32M14.85M12.51M13.38M13.22M13.76M11.86M12.49M10.99M10.73M12.71M
SG&A % of Revenue57.3%371.38%1443.77%455.27%60.63%42.18%38.51%58.95%34.2%26.79%45.56%49.87%30.84%125.72%17.14%7.4%93.41%40.58%204.61%219.3%
Research & Development17M17.52M20.93M24.48M23.27M29.58M34.89M43.78M39.13M58.67M53.57M36.62M51.08M52.67M51.77M26.98M37.69M38.19M44.89M32.63M
R&D % of Revenue92.9%591.92%3430.33%794.42%135.65%120.68%118.76%208.48%100.82%127.61%164.34%146.02%117.75%500.69%64.48%16.83%281.91%140.96%856.08%563.22%
Other Operating Expenses000-1000K-1000K-1000K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-9.19M-25.55M-29.78M-31.31M-16.51M-11.62M-16.83M-33.39M-10.74M-21.13M-30.41M-18.27M-19.31M-55.37M14.76M121.45M-36.81M-22.09M-50.38M-37.65M
Operating Margin %-50.2%-863.3%-4881.97%-1016.13%-96.27%-47.39%-57.27%-159.02%-27.66%-45.95%-93.29%-72.86%-44.53%-526.42%18.38%75.77%-275.32%-81.53%-960.7%-649.72%
Operating Income Growth %44.37%-119.91%-76.99%6.25%-53.79%45.02%44.67%-82.76%44.41%61.85%-306.11%-115.04%47.53%-150.69%129.29%422.62%31.61%58.88%12.64%-21.12%
EBITDA-9.19M-24.9M-29.12M-30.63M-15.75M-10.84M-16.02M-32.58M-9.82M-20.22M-29.51M-17.46M-18.49M-54.64M15.33M122M-36.39M-21.75M-50.16M-37.34M
EBITDA Margin %-50.2%-841.57%-4774.1%-994%-91.83%-44.21%-54.54%-155.12%-25.31%-43.97%-90.52%-69.61%-42.62%-519.41%19.1%76.11%-272.2%-80.29%-956.43%-644.37%
EBITDA Growth %41.68%-129.79%-81.73%5.99%-60.3%46.4%45.69%-86.6%46.85%63%-292.45%-114.31%49.2%-151.16%130.57%426.78%32.02%59.29%12.56%-21.17%
D&A (Non-Cash Add-back)0643K658K682K763K779K801K819K912K909K904K815K827K737K578K551K417K335K224K310K
EBIT0-23.79M-26.96M-20.82M-13.45M-9.18M-14.08M-30.01M-7.12M-17.37M-26.45M-11.44M-19.31M-55.37M14.76M121.45M-36.81M-22.09M-50.38M-37.65M
Net Interest Income01.82M1.93M1.53M3.23M2.57M2.77M3.21M7.64M4.15M4.02M6.88M3.98M3.25M2.48M1.02M-321K-560K-564K-524K
Interest Income01.82M1.93M1.53M3.23M2.57M2.77M3.21M7.64M4.15M4.02M6.89M4M3.25M3.22M1.81M444K168K154K184K
Interest Expense000000000004K20K0743K790K765K728K718K708K
Other Income/Expense1.77M1.76M2.82M2.22M3.06M2.44M2.75M3.38M3.62M3.76M3.96M6.83M3.98M3.4M36.1M-2.81M1.54M526K-790K-1.02M
Pretax Income-7.41M-23.79M-26.96M-29.08M-13.45M-9.18M-14.08M-30.01M-7.12M-17.37M-26.45M-11.45M-15.33M-51.97M50.86M118.64M-35.27M-21.56M-51.17M-38.66M
Pretax Margin %-40.52%-803.82%-4420.33%-943.95%-78.41%-37.44%-47.91%-142.9%-18.34%-37.77%-81.14%-45.64%-35.34%-494.09%63.35%74.02%-263.79%-79.59%-975.76%-667.29%
Income Tax-9.19M00-4K04K0-4K-217K-150K368K262K893K577K103K1.29M0000
Effective Tax Rate %123.91%0%0%0.01%0%-0.04%0%0.01%3.05%0.86%-1.39%-2.29%-5.83%-1.11%0.2%1.09%0%0%0%0%
Net Income1.77M-23.79M-26.96M-29.08M-13.45M-9.18M-14.08M-30M-6.9M-17.22M-26.82M-11.71M-16.22M-52.55M50.75M117.35M-35.27M-21.56M-51.17M-38.66M
Net Margin %9.69%-803.82%-4420.33%-943.82%-78.41%-37.45%-47.91%-142.88%-17.78%-37.45%-82.27%-46.68%-37.4%-499.57%63.22%73.21%-263.79%-79.59%-975.76%-667.29%
Net Income Growth %113.18%-159.1%-91.56%3.09%-94.81%46.68%47.51%-156.3%57.45%67.24%-152.84%-109.98%54%-143.7%199.19%403.51%34.79%60.49%9.19%-24.3%
Net Income (Continuing)1.77M-23.79M-26.96M-29.08M-13.45M-9.18M-14.08M-30M-6.9M-17.22M-26.82M-11.71M-16.22M-52.55M50.75M117.35M-35.27M-21.56M-51.17M-38.66M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.26-0.84-0.95-1.05-0.49-0.34-0.52-1.11-0.26-0.64-1.00-0.32-0.61-1.981.874.33-1.30-0.82-1.97-1.47
EPS Growth %46.94%-147.06%-82.69%5.41%-88.46%46.88%48%-246.88%57.38%67.68%-153.48%-107.39%53.08%-141.46%194.92%394.56%36.59%60.39%8.37%-23.53%
EPS (Basic)-0.26-0.84-0.95-1.05-0.49-0.34-0.52-1.11-0.26-0.64-1.00-0.32-0.61-1.981.914.43-1.30-0.82-1.97-1.47
Diluted Shares Outstanding28.44M28.42M28.42M27.39M27.19M27.13M27.11M27M27.06M26.97M26.88M26.63M26.57M26.56M27.15M27.08M26.47M26.43M26.38M26.36M
Basic Shares Outstanding28.44M28.42M28.42M27.39M27.19M27.13M27.11M27M27.06M26.97M26.88M26.63M26.57M26.56M26.55M26.51M26.47M26.43M26.38M26.35M
Dividend Payout Ratio--------------------